The Claim
Grapefruit juice inhibits intestinal OATP transporters and CYP3A4 enzymes, resulting in reduced absorption and increased systemic exposure of drugs such as fexofenadine and statins, leading to reduced efficacy or increased toxicity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Grapefruit juice blocks specific transporters and enzymes in the intestine that process certain drugs, causing higher levels of those drugs in the bloodstream and altering their effects.
See the scientific wording
Grapefruit juice inhibits intestinal OATP transporters and CYP3A4 enzymes, reducing the absorption and increasing the systemic exposure of drugs such as fexofenadine and statins, which can lead to either reduced efficacy or increased toxicity.
Compounds in grapefruit juice block special transporters in the gut that pull drugs into the bloodstream and stop enzymes that break down drugs, so more drug stays in the body longer and reaches higher levels than normal.
What the research says
1 studyStudy: Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds
This study shows that natural substances in plants can mess with how medicines work in your body—sometimes making them less effective or more dangerous. Grapefruit juice is one of those plant substances, so this research backs up the idea that it can interfere with certain drugs.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.